JACQUELYNN HOFFMAN: Open Payments
NPI 1306490248 · MEDINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 11 payments from 5 companies in 2025. Trend: 2023 $649 · 2024 $45 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 2 | $314 |
| E.R. Squibb & Sons, L.L.C. | 3 | $167 |
| Teva Pharmaceuticals USA, Inc. | 4 | $75 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
Products named: NUPLAZID, COBENFY, AUSTEDO XR, INGREZZA, REXULTI.
Industry payments across OH — which companies pay providers there.
